DSM-Firmenich AG has reinvited Apollo Global Management Inc. into the auction for its animal nutrition and health unit, establishing a two-way contest with CVC Capital Partners Plc. The sale has been complicated by persistent differences over price and the challenging vitamins business, which both buyout firms are reportedly pushing to have separated from the disposal.
The divestiture of DSM-Firmenich AG's animal nutrition and health unit is facing significant headwinds, casting uncertainty on the deal's valuation and timeline. The re-invitation of Apollo Global Management to compete against CVC Capital Partners has created a protracted auction process, indicating that a satisfactory bid has not yet materialized. The core of the problem lies in disagreements over price and the composition of the asset, specifically the "challenging vitamins part of the business." The fact that both potential buyers are pushing for this segment to be separated from the sale signals a consensus view that it either carries significant risk or is overvalued, complicating a straightforward transaction. This situation suggests DSM-Firmenich may be forced to either accept a lower price, restructure the deal by carving out the vitamins unit, or face a potential collapse of the sale process, reflecting the 'moderately negative' sentiment associated with the news.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment